The Use of the Functional Movement Screen™ in Preventing Injuries in Amateur Rugby Players

Launched by HOPITAL LA MUSSE · Nov 28, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how the Functional Movement Screen™ (FMS™) can help prevent injuries in amateur rugby players. Rugby is a very physical sport, and injuries are common due to the intense running, sudden changes in direction, and contact with other players. The goal of the study is to see if the FMS™, which assesses how well a player moves, can predict the risk of injury throughout the rugby season.

To participate, players must be male, at least 18 years old, and currently playing in the Fédérale 3 level with the French Rugby Federation. They should be healthy, without any recent injuries or surgeries. Throughout the study, players will take the FMS™ twice—once at the beginning and once at the end of the season—and will keep track of any injuries they experience during that time. This research hopes to find a link between FMS™ scores and injury rates, which could help rugby players stay safer and healthier on the field.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Players licensed with the French Rugby Federation (FFR): Their affiliation with the FFR requires a medical certificate confirming no contraindication to competitive sports practice.
• • Players aged at least 18 years old, legally adults.
• • Healthy players who have not sustained any musculoskeletal injuries or undergone surgical interventions in the past 6 months.
• • Players competing in "Fédérale 3."
• • Players from clubs based in Normandy.
• Exclusion Criteria:
• • Minor players
• • Female players
• • Players injured during the first interview or the first FMS™
• • Players who are or have been professional athletes
• • Players with a history of frequent serious injuries that could pose a risk to their continued participation